I started seeing it a few weeks ago, when Daily Kos told its contributors that after March 15th, they were no longer allowed to robustly criticize Hillary Clinton from the left. As Donald Trump continues to win, win, and win some more, it has only intensified. First they asked Bernie Sanders supporters to unite behind Clinton. Now they’re accusing Sanders supporters of being privileged if they resist. And from there, it’s just a small step to calling Sanders’ people enablers of racism, sexism, or even fascism. If you haven’t seen these arguments yet, you will soon. The arguments being peddled are very poorly constructed. They rely on a mix of fear and bias toward the near.
Tag: Economics
Should You Flee to Canada if Trump Wins?
Recently Canadian Prime Minister Justin Trudeau hung out with President Obama. The American left has been cooing all over Trudeau, and many people suggest they might move to Canada if Donald Trump becomes president. This idea of Canada as a haven for American progressives is an old one, and at times it has come in handy for Vietnam draft dodgers and runaway slaves. For many left-leaning democrats, Canada is considered something of a paradise, and in some ways it is–healthcare is a right of all people in Canada, and Canada scores better on life expectancy, homicide rate, obesity, social mobility, and in a number of other areas. But lately I get a sense that Americans are being perhaps a bit too utopian about Canada, and if you’re considering relocating, there are a few things you should know first.
Why Bernie vs Hillary Matters More Than People Think
Lately the internet has become full of arguments about the merits and demerits of Bernie Sanders and Hillary Clinton. Over the past couple weeks, I’ve been discussing and pondering all the various views about this, and I’m increasingly of the opinion that most of the people engaging in this debate don’t really understand what is at stake in the democratic primary. This is in part because many Americans don’t really understand the history of American left wing politics and don’t think about policy issues in a holistic, structural way. So in this post, I want to really dig into what the difference is between Bernie and Hillary and why that difference is extremely important.
Continue reading “Why Bernie vs Hillary Matters More Than People Think”
The Democratic Party Debate: 5 Reasons Why Sanders Won and Clinton Lost
I watched the first Democratic Party debate, hosted by CNN. CNN also hosted the second Republican Party debate, and in both debates it tried to get the candidates to fight each other on camera for the entertainment of the viewing public, repeatedly asking questions designed to get candidates to criticize or attack one another. In the republican debate, this tactic worked perhaps too well–the debate deteriorated into a series of personal attacks, with little relevant policy content. For that reason, I didn’t bother to write up an analysis of the second republican debate–there was little of substance to analyze. The democratic candidates did a better job of resisting their baser instincts, and we did manage to get some interesting exchanges on serious policy issues, particularly between Bernie Sanders and Hillary Clinton. In these exchanges, it was quite clear that Sanders was the winner–his arguments were significantly stronger and more convincing than Clinton’s.
Continue reading “The Democratic Party Debate: 5 Reasons Why Sanders Won and Clinton Lost”
Martin Shkreli is the Product of a Broken Healthcare System
A lot of people are very angry with Martin Shkreli. Shkreli is CEO of Turing Pharmaceuticals. Turing recently purchased the rights to Daraprim, a drug that treats toxoplasmosis, a condition that poses the greatest threat to people with weakened immune systems, such as AIDS patients. 4,400 people are hospitalized with the condition each year in the US, and about 327 people die on average each year. Once Turing acquired Daraprim, it promptly raised the price from $13.50 per pill to $750. Turing and Shkreli claimed that the price increase was necessary to make a profit and to pay for research and development into new toxoplasmosis drugs, but the medical establishment and the public strongly disagree. Dr. David Relman, chief of infectious diseases at VA Palo Alto Healthcare System, told Fortune:
We are not in dire need of new drugs for toxoplasmosis right now. There is no significant drug resistance problem with toxoplasmosis. We do not need them to be undertaking some self-serving marketing campaign. There is no public health need for such. This is simply about greed.
The HIV Medicine Association and the Infectious Diseases Society of America concurred, writing a joint letter condemning the move. But in going after Shkreli and Turing individually, we’re collectively missing the point–they are a symptom of a much larger prescription drug problem in America.
Continue reading “Martin Shkreli is the Product of a Broken Healthcare System”
Benjamin Studebaker 